Key result
Elevated serum NGAL distinguishes ACS from stable angina with ~0.93 AUC.
Why the study?
Atherosclerosis is a chronic inflammatory disease with acute clinical manifestations, and it was hypothesized that blood neutrophil gelatinase-associated lipocalin (NGAL) levels may reflect the inflammatory process across various stages of coronary artery disease.
Cross-Sectional (n=160)
Assessor-blinded (2 cardiologists blinded to NGAL results determined final diagnosis)
No
Answers are grounded in this paper and cite their sources.
NGAL may mark inflammatory activity across CAD stages; leaves open its incremental diagnostic or prognostic value.
Background. Atherosclerosis is a chronic inflammatory disease and the acute clinical manifestations represent acute on chronic inflammation. Neutrophil gelatinase-associated lipocalin (NGAL) is found in the granules of human neutrophils, with many diverse functions. The aim of this study was to evaluate the hypothesis that levels NGAL in blood may reflect the inflammatory process in various stages of coronary artery disease. Methods. We studied 140 patients, with SA 40, UA 35, NSTEMI 40, and STEMI 25, and 20 healthy controls. Serum NGAL was measured upon admission and before coronary angiography. Results. Significant differences were observed in median serum-NGAL(ng/mL) between patients with SA (79.23 (IQR, 37.50-100.32)), when compared with UA (108.00 (68.34-177.59)), NSTEMI (166.49 (109.24-247.20)), and STEMI (178.63 (111.18-305.92)) patients and controls (50.31 (44.30-69.78)) with significant incremental value from SA to STEMI. We observed a positive and significant correlation between serum-NGAL and hs-CRP (spearman coefficient rho = 0.685, P < 0.0001) as well as with neutrophil counts (r = 0.511, P < 0.0001). Conclusions. In patients with coronary artery disease serum levels of NGAL increase and reflect the degree of inflammatory process. In patients with acute coronary syndromes, serum levels of NGAL have high negative predictive value and reflecting the inflammatory status could show the severity of coronary clinical syndrome.
No takes yet. Share an insight, caveat, or question.
Kafkas et al. (2012) conducted a cross-sectional in Coronary artery disease (stable angina, unstable angina, NSTEMI, and STEMI) (n=160). Serum neutrophil gelatinase-associated lipocalin (NGAL) levels across coronary artery disease stages vs. Healthy controls and stable angina (SA) patients was evaluated on Median serum NGAL levels (ng/mL) across CAD severity groups (STEMI vs healthy controls) and correlation with hs-CRP (Spearman rho 0.685 (correlation with hs-CRP); AUC 0.929 (ACS vs SA), p=<0.001). Serum NGAL increased incrementally from controls and SA to STEMI, discriminating ACS from SA with an AUC of 0.929.
Synapse has enriched 10 related papers. Consider them for comparative context: